Published in Blood Weekly, August 29th, 2002
Human hematopoietic stem cell transfection can be problematic when retroviral vectors are the gene transfer vehicle, according to Y. Hanazono and colleagues, Jichi Medical School, Tochigi, Japan.
"Strategies that would allow in vivo expansion of gene-modified hematopoietic cells could circumvent the problem," Hanazono and colleagues argued.
The multicenter team, which included investigators from both Japan and the U.S.,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2002-08-29)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.